Is this email not displaying correctly?   ADVERTISEMENT AC2024-Call-for-Abstracts728x90 NCCN-Ebulletin-Headers        September 18, 2023 PED-ALL-Webinar-Ads460x212-lighter (003) UPCOMING FREE PATIENT WEBINAR Join us on October 18 for the FREE patient webinar focusing on pediatric acute lymphoblastic leukemia. Participants will understand diagnosis and treatment of pediatric acute lymphoblastic leukemia, and more. Register now SEE YOU IN SAN FRANCISCO OR VIRTUALLY FOR THE HEMATOLOGIC MALIGNANCIES CONGRESS! The Congress starts Friday and we look forward to connecting with our in-person and virtual attendees. There is still time to register virtually in order to access educational sessions and more! Learn more NCCN GLOBAL ACADEMY FOR EXCELLENCE & LEADERSHIP IN ONCOLOGY™ One month away! Join us in Madrid, Spain to learn about patient involvement in the scientific process and drug development, and more. Enroll now NA-N-0369-0523-September-2023-Academy-460x212 LIVE EVENTS Tomorrow! Global Policy Webinar: Non-Medical Influences and Barriers to Access High-Quality Cancer Care Globally Virtual Attendance | September 19, 2023 Register This week! NCCN 2023 Annual Congress: Hematologic Malignancies™ San Francisco, CA and Virtual Attendance | September 22 - 23, 2023  Register Next week! NCCN Academy for Excellence & Leadership in Oncology™: School of Pharmaceutical & Biotech Business Philadelphia, PA | September 28, 2023 Enroll   NCCN Global Academy for Excellence & Leadership in Oncology™: School of Pharmaceutical & Biotech Business Madrid, Spain | October 19, 2023 Enroll   CLINICAL WEBINARS (CE/CME) This week! Monthly Oncology Tumor Boards: Management of Differentiated and Medullary Thyroid Carcinomas September 25, 2023 Register Monthly Oncology Tumor Boards: Identification and Management of Immuno-Oncology Targeted Therapy-Related Adverse Events in Renal Cell Carcinoma October 17, 2023  Register PATIENT WEBINARS Pediatric Acute Lymphoblastic Leukemia October 18, 2023 Register NCCN GUIDELINES® UPDATES NCCN Flash Updates: NCCN Guidelines Updated for Basal Cell Skin Cancer (September 15, 2023)  View ---------------------------------------------------------------------------------------------------------------------------------- NCCN IN THE NEWS HealthDay: Few With CRC in Sub-Saharan Africa Receive Guideline-Concordant Care (September 12, 2023) Read More ---------------------------------------------------------------------------------------------------------------------------------- Physician's Weekly: Linguistic Disparities Impact Patient Access to Cancer Care (September 11, 2023) Read More ---------------------------------------------------------------------------------------------------------------------------------- HealthDay: Cancer Care Tougher to Access in U.S. If English Second Language (September 11, 2023) Read More ---------------------------------------------------------------------------------------------------------------------------------- The Cancer Letter: Crystal Denlinger Named the First Woman to Lead NCCN  (September 8, 2023) Read More ---------------------------------------------------------------------------------------------------------------------------------- NEWS FROM NCCN MEMBER INSTITUTIONS Potent Oral Agent Acting as Immunotherapy and Targeted Treatment Produces High Response Rate in Certain Patients (Dana-Farber/Brigham and Women's Cancer Center | Mass General Cancer Center) Read More ---------------------------------------------------------------------------------------------------------------------------------- Mayo Clinic Researchers Publish Key Findings About Cell Proteins To Determine Effectiveness Of Immunotherapy For Colon Cancer (Mayo Clinic Comprehensive Cancer Center) Read More    ---------------------------------------------------------------------------------------------------------------------------------- Enhanced Recovery Program Successfully Reduced Opioid Use After Pancreatic Cancer Surgery (The University of Texas MD Anderson Cancer Center) Read More ---------------------------------------------------------------------------------------------------------------------------------- Breakthrough Targeted Therapy Approach for Non-Small Cell Lung Cancer Helps Patients With a Genetic Mutation Live Longer (Yale Cancer Center/Smilow Cancer Hospital) Read More ---------------------------------------------------------------------------------------------------------------------------------- ADVERTISEMENT France_Foundation_NCCN_disparities_ad_468x60 > About NCCN > NCCN Annual Report > NCCN Guidelines® > NCCN Store > Patient Resources  > Event Calendar > JNCCN > Online Catalog FOLLOW US Facebook Twitter LinkedIn Instagram ADVERTISEMENT Amgen, Kyprolis   ADVERTISEMENT Karyopharm   ADVERTISEMENT Gallbladder-Cancer160x600 Forward to a Friend Search past NCCN eBulletins EB-N-0805-0923 If you would like to subscribe to NCCN eBulletin and receive other information from NCCN, click here to register. If you would like to update your e-mail preferences, click here to update or opt-out. National Comprehensive Cancer Network | 3025 Chemical Road, Suite 100 | Plymouth Meeting | PA | 19462 | US | 215.690.0300 ---------------------------------------------------------------------------------------------------------------------------------- Cvent - Web-based Software Solutions